Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan

NCT05734339 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05734339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05734339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
January 19, 2023
Completion date
February 3, 2025
Enrollment
43 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

asthma